Skip to main content
. Author manuscript; available in PMC: 2015 Mar 3.
Published in final edited form as: J Immunol. 2012 Sep 12;189(8):4014–4023. doi: 10.4049/jimmunol.1200798

Table VII.

Charge associations with disease after adjustment for E69 status

One or Two at −9 and None at −7 versus One or Two at −7 and None at −9 p One at −9 and One at −7 versus One or Two at −7 and None at −9 p value Othera versus −7 p
CBD versus controls 4.1 (2.5–6.5) <0.0001 3.3 (1.7–6.5) <0.0005 0.83 (0.41–1.7) 0.60
BeS versus controls 2.4 (1.5–4.1) 0.0007 2.5 (1.2–5.3) 0.02 1.4 (0.65–3.1) 0.38
Case versus control 3.3 (2.1–5.0) <0.0001 2.7 (1.4–5.1) 0.0021 1.01 (0.60–1.7) 0.96
CBD versus BeS 1.7 (1.04–2.6) 0.03 1.3 (0.67–2.5) 0.44 0.60 (0.21–1.7) 0.33

Odds ratios (95% confidence intervals) for case control comparisons are shown.

a

Any other combination of charges not including −9 or −7.